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Antiviral immunity is triggered by immunorecognition
of viral nucleic acids. The cytosolic helicase RIG-I is
a key sensor of viral infections and is activated by
RNA containing a triphosphate at the 50 end. The
exact structure of RNA activating RIG-I remains con-
troversial. Here, we established a chemical approach
for 50 triphosphate oligoribonucleotide synthesis and
found that synthetic single-stranded 50 triphosphate
oligoribonucleotides were unable to bind and acti-
vate RIG-I. Conversely, the addition of the synthetic
complementary strand resulted in optimal binding
and activation of RIG-I. Short double-strand confor-
mation with base pairing of the nucleoside carrying
the 50 triphosphate was required. RIG-I activation
was impaired by a 30 overhang at the 50 triphosphate
end. These results define the structure of RNA for full
RIG-I activation and explain how RIG-I detects
negative-strand RNA viruses that lack long double-
stranded RNA but do contain blunt short double-
stranded 50 triphosphate RNA in the panhandle
region of their single-stranded genome.
INTRODUCTION
Antiviral innate and antigen-specific immunity is triggered by
immunorecognition of viral nucleic acids. The receptor repertoire
of the innate immune system is genetically programmed to
detect a wide range of viral infections and activate a set of genes
including type I interferons (IFNs), which confer antiviral activity
to the host (Samuel, 2001). Long double-stranded RNA is widely
accepted as a virus-associated nucleic acid pattern normally
absent in mammalian cells. Receptors proposed to detect long
double-stranded RNA include double-stranded RNA-activated
protein kinase ‘‘PKR’’ (Manche et al., 1992) as well as the two
helicases MDA-5 (Gitlin et al., 2006; Kang et al., 2002; Kato
et al., 2008; Kato et al., 2006; Takahasi et al., 2008; Yoneyamaet al., 2004) and RIG-I (Yoneyama et al., 2004). RIG-I is a key
sensor of negative-strand RNA viruses (Habjan et al., 2008;
Plumet et al., 2007; Takeuchi and Akira, 2008). The presence
of a triphosphate group at the 50 end of RNA (50 triphosphate
RNA) is another molecular feature that is recognized by the
innate immune system (Hornung et al., 2006; Kim et al., 2004;
Nallagatla et al., 2007; Pichlmair et al., 2006). A triphosphate is
initially present at the 50 end of any viral or self-RNA molecule
generated by RNA polymerases; however, in eukaryotes, RNA
is processed and modified by cleavage, capping, and base
modifications in the nucleus before the RNA is released to the
cytoplasm. Most studies agree on the fact that single-stranded
50 triphosphate RNA is sufficient to bind to and activate RIG-I
(Cui et al., 2008; Hornung et al., 2006; Pichlmair et al., 2006;
Plumet et al., 2007; Saito et al., 2008; Takahasi et al., 2008).
Recent work suggests that long (>300 bp) double-stranded
RNA can substitute for the presence of a 50 triphosphate group
(Kato et al., 2008). However, in the life cycle of negative-strand
RNA viruses, such double-stranded RNA is absent (Pichlmair
et al., 2006; Weber et al., 2006), and 50 triphosphate single-
stranded RNA seems the prime RIG-I ligand. Here, we generated
fully synthetic well-characterized 50 triphosphate RNA and to our
surprise found that 50 triphosphate single-stranded RNA is not
a ligand for RIG-I but that a 50 triphosphate short blunt-end
double-strand RNA structure as contained in the panhandle of
negative-strand viral genomes confers full RIG-I ligand activity
to a RNA molecule.
RESULTS
Synthetic 50 Triphosphate Single-Stranded RNA
Is Not Sufficient to Activate RIG-I
A 24-mer RNA oligonucleotide with 50-G (3P-G) was designed for
which self-complementarity and thus secondary structure forma-
tion (intra- or intermolecular double-strand formation) was pre-
dicted to be absent (see Table S1 available online). A triphos-
phate group was covalently attached to the 50 end of the
corresponding synthetic oligonucleotide with a previously estab-
lished method (Ludwig and Eckstein, 1989). Purity of RNA oligo-
nucleotides was confirmed with HPLC (high-performance liquidImmunity 31, 25–34, July 17, 2009 ª2009 Elsevier Inc. 25
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Short Blunt 3P-dsRNA Recognition by RIG-Ichromatography) and MALDI-ToF-MS (matrix-assisted laser
desorption ionization mass spectrometry) (exemplary spectra
for ‘‘3P-A’’ are shown in Figures 1A–1C). The same sequence
(ivt3P-G) and a positive control oligonucleotide (IVT2, 30-mer,
Table S1) were generated by in vitro transcription. The RIG-I
activity of RNA oligonucleotides was examined in primary human
monocytes (Hornung et al., 2006). Unexpectedly, synthetic 3P-G
showed no IFN-a induction (Figure 1D). Polyacrylamide gel anal-
ysis revealed that unlike synthetic 3P-G, ivt3P-G presented as
two major bands (Figure 1E, lane 5 versus lane 1). It has been
reported that during IVT reactions, RNA-template-dependent
RNA transcription (Cazenave and Uhlenbeck, 1994; Triana-
Alonso et al., 1995) can lead to complementary side products
and to double-stranded RNA products that were originally
designed to be single stranded. Indeed, the addition of a fully
synthetic complementary single strand (not containing a triphos-
phate group, ASG24) to synthetic 3P-G (3P-G+ASG24) led to full
RIG-I ligand activity (Figure 1D).
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Figure 1. Fully Synthetic 50 Triphosphate
Single-Stranded RNA Is Not Sufficient for
RIG-I Activation
(A) Reverse-phase HPLC analysis of 3P-A =
pppAAC ACA CAC ACA CAC ACA CAC UUU after
deprotection under standard ACE deprotection
conditions (pH = 3.8, 60C in 30 min).
(B) MALDI-ToF analysis of 3P-A: calculated
molecular weight of 3P-A is 7770; the peak at
3886 represents the double-charged peak (z = 2).
(C) MALDI-ToF analysis of 3P-A mixed with HO-A.
The difference between the molecular weight of
the product 3P-A (1) and the educt HO-A (2) is
240, which corresponds to the molecular weight
of an additional triphosphate group (H3P3O9).
(D) Purified monocytes were stimulated with the
indicated single-stranded or double-stranded
synthetic or in vitro-transcribed RNA oligonucleo-
tides. The question mark indicates that the 30 end
of this in vitro-transcribed RNA is not molecularly
defined. IFN-a productionwas analyzed 24 hr after
stimulation. Data from four independent donors
are depicted as mean values ± SEM.
(E) Indicated RNA stimuli (see Table S1) were
analyzed on a denaturing 12% polyacrylamide
gel (containing 50% urea w/v) and stained with
methylene blue detecting single-stranded and
double-stranded RNA. ivt3P-G without U was
generated by in vitro transcription in the absence
of the nucleotide UTP.
(F) Purified monocytes were stimulated with the
indicated single-stranded or double-stranded
synthetic or in vitro-transcribed RNA oligonucleo-
tides. IFN-a production was analyzed 24 hr after
stimulation. Data from four independent donors
are depicted in the bar graph as mean values ±
SEM. RNAs were analyzed on a denaturing 12%
polyacrylamide gel (containing 50% urea w/v)
and stained with methylene blue.
We then changed the sequence of
3P-G to 3P-Gaca by replacing the three
30 UUU to 30ACA (see Figure 1F, right
panel). The in vitro transcription of 3P-
Gaca requires only three nucleotides, G, C, and A, but not U in
the in vitro reaction mix. Therefore, double-strand formation
can only occur in the presence of U. Consistent with the results
obtained with defined synthetic RNAs, we found that ivt3P-Gaca
strongly induced IFN-a, whereas ivt3P-Gaca without U (absence
of uridine in reaction mix, no double strand expected) showed no
IFN-a induction (Figure 1F). However, the addition of the 21-mer
complementary strand (ASG21) restored IFN-a-inducing activity
of ivt3P-Gaca without U. In order to retrieve complementary
species in the ivt3P-Gaca reaction mix, we performed digestion
with RNase T (Figure S1). RNase T cleaves after G in single-
stranded RNA. Under native cleaving conditions (37C), only
a small fraction of small RNA species (<10 nt) disappeared
from the reaction mix (Figure S1, upper-right panel, ivt3P-
Gaca). In contrast, almost all RNA species with the exeption of
the main band disappeared when digestion was performed
under denaturating conditions (lower-right panel). These results
strongly suggested that the RNA mix contains substantial26 Immunity 31, 25–34, July 17, 2009 ª2009 Elsevier Inc.
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promoter-containing DNA template. The protection of the
G-rich species from digestion under native conditions implies
the presence of double-stranded RNA and therefore comple-
mentary RNA, which cannot be cleaved by RNase T. In order
to identify the immunostimulatory RNA species of the ivt3P-
Gaca reaction, we extracted RNA from different bands of the
PAGE (Figure S2). Although the diffuse band (25–35 nt) above
the main band contained almost the whole IFN-a-inducing
activity, RNA retrieved from the main band was nearly inactive.
Although RNA from the band 3 (10–15 nt) had no IFN-a-inducing
activity by itself, it was as active as ivt3P-Gaca when added to
ivt3P-Gaca without U (Figures S2A–S2C). Reverse cloning of
RNA and sequencing revealed the presence of sequences
generated by self-coding intramolecular 30 extension (Triana-
Alonso et al., 1995), which form blunt-ended double-stranded
RNA (Figure S2F). In addition, complementary poly-GU se-
quences were found in both band 1 (e.g., a 17-mer was found, 7)
and band 3 (9–12-mer) (Figure S2E). Given that the sequences
start with a G (Figures S2E and S7–S12), sequences were gener-
ated by transcript-coded ‘‘de novo’’ synthesis (Cazenave and
Uhlenbeck, 1994; Triana-Alonso et al., 1995). Thus, the use of
synthetic 50 triphosphate RNA revealed that a single strand is
not sufficient to support RIG-I activation; furthermore in the
case of IVT, the formation of unexpected transcripts and not
the intended single-stranded RNA are responsible for RIG-I acti-
vation.
RIG-I Activation Requires a Short Double-Stranded
RNA with a 50 Triphosphate
Next, the length of the strand complementary to 3P-G (AS G24)
was decreased from 24 down to 13 nucleotides (3P-G with
A C
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Figure 2. RIG-I Activation Requires a Short
Double Strand and Prefers 50 Adenosine
Purified monocytes were stimulated with the
indicated single-stranded or double-stranded
synthetic RNA oligonucleotide. IFN-a production
was analyzed 24 hr after stimulation. Data from n
independent donors are depicted as mean values
± SEM, n as indicated.
(A) 3P-A was hybridized with synthetic antisense
single-stranded RNA with different lengths gener-
ating double-stranded RNA with blunt end
carrying the triphosphate group.
(B) 23-mer (AS G23 and AS A23) with a blunt
triphosphate end and a 30overhang at the nontri-
phosphate end.
(C) Comparison of RIG-I ligand activity of 3P-G to
the other three synthetic variants (3P-A, 3P-C, and
3P-U), which were hybridized with the corre-
sponding synthetic 24-mer (AS-A24, AS-C24,
and AS-U24) or used as single strands.
(D) IFN-a-inducing activity of 3P-A+AS A24 and
3P-G+AS G24.
complementary AS G24 to AS G13, see
Figure 2A, and Table S1). We found that
with the sequence 3P-G, AS G21 was
the minimal tolerated length of a comple-
mentary strand (Figure 2A). AS G23
together with 3P-G (one nucleotide 30 overhang at the nontri-
phosphate end) consistently showed slightly higher activity
than AS G24 (no overhang at the nontriphosphate end); the
same was seen for AS A23 and AS A24 with 3P-A (Figure 2B),
suggesting that blunt-end formation at the nontriphosphate
end is not preferred.
To analyze the contribution of the 50 nucleoside of the triphos-
phate strand, we compared the RIG-I ligand activity of 3P-G to
the other three synthetic variants (3P-A, 3P-C, and 3P-U). Inter-
estingly, all 50 nucleosides induced substantial amounts of IFN-a,
with a preference for 50 adenosine and 50 guanosine with 50 aden-
osine being slightly but significantly higher than 50 guanosine
(Figures 2C and 2D). The response was weakest for a 50 cytidine.
Furthermore, elongation of the complementary strand at the
nontriphosphate end by one or two nucleosides did not reduce
but rather increased the IFN-a-inducing activity for both 3P-G
and 3P-A (Figure 3A).
Unlike the nontriphosphate end, elongation at the triphosphate
end reduced RIG-I ligand activity (Figure 3B and Figure S3B).
RIG-I ligand activity was specifically sensitive to shortening of
the complementary strand, resulting in a 50 overhang at the
triphosphate end (3P-G+AS 23, 3P-G+AS 21, and 3P-G+AS 19;
Figure 3C). Next, we compared synthetic 50 monophosphate
single-stranded RNA (P-A, P-G, P-U, and P-C) to synthetic 50
triphosphate single-stranded RNA (3P-A) and varied the length
of the complementary strand in order to study the contribution of
blunt end (Figure 3D). Compared to the 50 triphosphate version of
the same sequence, we found no considerable IFN-a induction
by 50 monophosphate blunt-end double-stranded RNA (P-N +AS
N24; N = A, G, U, and C) or 50 monophosphate RNA with a two
nucleotide 30 overhang (P-N+AS N26) or a 50 overhang
(P-N+AS23) at the monophosphate end (Figure 3D).Immunity 31, 25–34, July 17, 2009 ª2009 Elsevier Inc. 27
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50 Triphosphate RNA as Contained in Viral
Panhandle Structures
Additional sequences were examined with different degrees of
secondary structure formation. 3P-GFP2 and 3P-GFP3 repre-
sent variations of 3P-GFP1 (Hornung et al., 2006). 3P-GFP1
forms a 4 bp hairpin and 3P-GFP3 forms a 6 bp hairpin.
3P-GFP2 is not self-complementary. Consistent with the data
obtained with 3P-G and 3P-A, none of the additional sequences
by itself induced IFN-a in primary human monocytes; addition of
the complementary strand to 3P-GFP2 resulting in a blunt-
end double-stranded RNA induced a full IFN-a response (Fig-
ure 4A). Next, 3P-GFP2 was hybridized with complementary
RNA of different lengths and at different positions (Figure 4B).
In agreement with the results obtained with 3P-G and 3P-A,
the activity of 3P-GFP2 required a minimal length of 19 base
pairs double strand as long as the triphosphate end was blunt.
Elongation of the complementary strand at the triphsophate
end by three nucleosides (30 overhang) strongly reduced the
IFN-a-inducing activity. Shortening of the complementary strand
at the triphsophate end by one, two, or three nucleosides (50
overhang) abolished the activity. Next, the impact of mismatches
in short double-stranded RNA on RIG-I activity was analyzed. A
mismatch at the first position at the triphosphate end abolished
the activity, whereas a wobble base pair at the first position or
A B
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Figure 3. Blunt End at the Triphosphate End
but Not at the Nontriphosphate End Con-
tributes to RIG-I Ligand Activity, and 50
Monophosphate Does Not Substitute for 50
Triphosphate
Purified monocytes were stimulated with the
indicated single-stranded or double-stranded
synthetic RNA oligonucleotides. IFN-a production
was analyzed 24 hr after stimulation. Data from
four independent donors are depicted as mean
values ± SEM. 3P-G and 3P-A were hybridized
with corresponding antisense strands with dif-
ferent lengths and positions.
(A) The use of 25-mer (AS G24+A and AS A24+A)
and 26-mer (AS G24+2A and AS A24+2A) results
in a mononucleotide or dinucleotide 50 overhang
at the nontriphosphorylated end.
(B) The use of 25-mer (AS G25 and AS A25) and
26-mer (AS G26 and AS A26) results in a mononu-
cleotide or dinucleotide 30 overhang at the triphos-
phate end.
(C) The use of 19-mer, 21-mer, and 23-mer single-
stranded antisense RNA (AS19, AS21, and AS23)
results in a 50 overhang at the triphosphate end
(5nt, 3nt, and 1nt).
(D) IFN-a-inducing activity of single-stranded 50
monophosphate RNA (P-A, P-G, P-U, and P-C),
synthetic 50 triphosphate single-stranded RNA
(3P-A), and combinations with complementary
strands of different lengths are compared.
a mismatch at the second position were
partially tolerated (Figure 4C). Further-
more, a 3 nt bulge loop starting at position
8 from the triphosphate end was well
tolerated (Figure 4C). Such bulge loop
structures are contained in predicted panhandle structures of
(-)ssRNA virus genomes (Figure S4). We generated in vitro-tran-
scribed RNA corresponding to the predicted Rabies genome
panhandle. In this construct, 40 nt of the 50 end of the Rabies
genome is connected by a 5 nt loop to the 40 nt 30 end of the
Rabies genome (resulting in a blunt end). A second RNA tran-
script was prepared (Rabies panhandle mismatch), identical to
the first transcript except for an additional 30 overhang and two
mismatched nucleotides at the triphosphorylated end (no blunt
end, see Table S1). PAGE purification of the two RNA transcripts
was used for isolating the correct RNA molecules from the RNA
molecules generated by in vitro transcription. The blunt-end
Rabies panhandle RNA was more potent than the RNA that con-
tained the 50 mismatches and the 30 overhang (Figure 4D). The
residual activity of the 30 overhang RNA may be due to partial
contamination with blunt-ended byproducts. Thus, double-
stranded blunt-end 50 triphosphate RNA with bulges as con-
tained in viral panhandle structures is recognized by RIG-I.
Synthetic Short Double-Stranded 50 Triphosphate RNA
Is Recognized by RIG-I but Not MDA-5
Mouse embryonic fibroblasts (MEFs) prepared from mice defi-
cient of RIG-I (Ddx58/), MDA-5 (Ifih1/), or IPS-1 (Mavs/)
were stimulated with blunt-end short double-stranded RNA
(3P-GFP2 + AS GFP2 5024) or with short double-stranded RNA28 Immunity 31, 25–34, July 17, 2009 ª2009 Elsevier Inc.
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GFP2 + AS GFP2 5021) or the triphosphate end (3P-GFP2 + AS
GFP2 3021). Consistent with the results obtained in human
monocytes, MEFs produced IFN-b in response to the blunt-
end double-stranded RNA (3P-GFP2 + AS GFP2 5024) or the
double-stranded RNA with the overhang at the nontriphosphate
end (3P-GFP2 + AS GFP2 5021); almost no activity was seen in
response to double-stranded RNA with the overhang at the
triphosphate end (3P-GFP2 + AS GFP2 3021) (Figure 5). For all
three double-stranded RNA molecules, IFN-b production
required the presence of RIG-I and IPS-1, but not MDA-5.
IFN-a Induction Correlates with Induction of ATPase
Activity of Purified RIG-I
Next, we studied whether IFN-a induction by RNA correlates
with the induction of RIG-I ATPase activity in vitro. First we
analyzed ATPase activity in response to direct interaction of puri-
fied human RIG-I protein isolated from HEK293T cells with
different single-stranded and double-stranded RNA ligands.
Single-stranded RNA (all open symbols) irrespectively of 50
triphosphate or 50 monophosphate did not induce ATPase
activity (Figure 6A). Double-stranded RNA molecules (all black
symbols) showed an EC50 in the range of 15 nM to 600 nM
depending on the composition of the double strand and the
configuration of the 50 end (Figure 6A). Double-stranded RNA
with 50 monophosphate or RNA without 50 phosphate (P–A+AS
A24, HO-A+AS A24) showed a 35- and 20-fold higher EC50
(lower ATPase activity) than double-stranded RNA with
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Figure 4. RIG-I Is Not Activated by Highly
Structured 3P-ssRNA and Tolerates Central
but Not Distal Mismatches of 3P-dsRNA
Purified monocytes were stimulated with the
indicated single-stranded or double-stranded
synthetic RNA oligonucleotides. IFN-a production
was analyzed 24 hr after stimulation. Data from
four independent donors are depicted as mean
values ± SEM. Analyses of (A) related 3P-RNAs
(3P-GFP1 [Hornung et al., 2006] and variations
thereof), with gradual stability of secondary struc-
ture, (B) 3P-GFP2 hybridized with corresponding
antisense strands with different lengths and posi-
tions as indicated, (C) 3P-GFP2 hybridized with
corresponding antisense strands with single or
multiple mismatched nucleotides at different posi-
tions as indicated, and (D) PAGE-purified in vitro
transcripts corresponding to the predicted pan-
handle structure of Rabies virus genomewith blunt
end (match) and with 30 overhang of a poly A tail
and a mismatched (2 nt) triphosphorylated end
(mismatch) are shown.
Figure 5. Synthetic 3P-dsRNA Is Recognized by RIG-I
Mouse embryonic fibroblasts (MEFs) with indicated genotype were trans-
fected with indicated 3P-dsRNA. Ifih1(+/+) and Mavs (+/+) represent wild-type
MEFs with the same passage number as the corresponding mutant MEFs
Ifih1 (/) and Mavs (/), respectively. Triplicate data of a representative
experiment are depicted as mean values ± SEM.
a 50 triphosphate (Figure 6A). The 50
triphosphate double-strandedRNAmole-
cules that induced substantial amounts of
IFN-a in monocytes (3P–A+AS A24, 3P-
A+AS A23, and 3P-A+AS A21; see
Figure S3A) reached their EC50 at 95%
to 99% lower concentrations than dsRNA
ligands that weakly induced IFN-a (3P-
A+AS A34, 3P-A+AS23, and 3P-A+ASA19) (Figure 6B, compare
to Figures S3A and S3B). The ATPase activities of different 50
triphosphate RNAs with different 50bases (3P-A+AS A24,Immunity 31, 25–34, July 17, 2009 ª2009 Elsevier Inc. 29
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Figure 6. IFN-a-Inducing Activity of RIG-I
RNA Ligands Correlates with RIG-I ATPase
Activity and with RIG-I-Binding Affinity
(A) For the ATPase assay purified RIG-I protein
was incubated with increasing amounts of indi-
cated RNA molecules (from 109 nM to 1800 nM)
and the release of ADP was analyzed after 30
min at 37C by a FRET-based competitive immu-
noassay. The percentage of ADP release is plotted
against the decadic logarithm of the concentration
of indicated RNAs. Triplicate data of a representa-
tive experiment are depicted as mean values ±
SEM. Half effective concentration (EC50) was
determined by statistical analysis (nonlinear
regression). Low EC50 represents high RIG-I
ATPase activity.
(B) The EC50 of the synthetic 3P-A hybridized with
the indicated antisense RNAs are compared.
(C) The EC50 of 5
0 triphosphate double-stranded
RNA with different 50 bases (A, G, U, and C) are
compared.
(D–G) Alpha screen: Purified (His6)-tagged RIG-I
was incubated with different RNA molecules
bearing a biotin (*) on the 50 end of the antisense
strand (at the nontriphosphate end of the double-
stranded RNA; D–F) or at the 30 end of the
3P-bearing strand (G). (His6)-tagged RIG-I protein
was bound to Ni-chelate beads (donor); biotiny-
lated RNA was bound to streptavidine beads
(acceptor). The resulting fluorescence correlates
with the number and proximity of interacting
donor-acceptor pairs. The concentration of indi-
cated RNAs is plotted against the percentage of
maximum binding to RIG-I. The dissociation
constant Kd(app) is calculated by statistical anal-
ysis (nonlinear regression).
(E–G) Kd(app) of nonmodified, monophosphate,
and triphosphate RNAs hybridized to indicated
antisense RNAs of different lengths are compared.
(F) CIAP 3P-A + AS A24 was incubated with active
alkaline phosphatase; the other stimuli were incu-
bated with heat-inactivated active alkaline phos-
phatase.
(H) Purified (His6)-tagged RIG-I protein was
analyzed by SDS-PAGE and Coomassie Blue
staining.3P-G+AS G24, 3P-U+AS U24, and 3P-C+AS C24, Figure 6C) re-
flected the observed IFN-a-inducing activity (A, G > U > C, see
Figure 2C). These data demonstrate that the IFN-a-inducing
activity of RIG-I ligands correlates with ATPase activity.
High-Affinity Binding of RNA to RIG-I Requires
Double-Stranded RNA with a 50 Triphosphate
Using a homogenous ligand interaction assay, we analyzed the
affinity of different RNA molecules to RIG-I. We found that
binding of RNA to RIG-I strictly depended on the presence of
a triphosphate at the 50 end and on the presence of short
double-stranded RNA (Figures 6D, 6E, and 6G). The dissociation
constant of 50 triphosphate RNA (3P-A+ASA24 and 3P-VH1 +AS
VH1) was between 4 nMand 9 nM. The Kd(app) of corresponding
nonmodified RNA, 50 monophosphate RNA, dephosphorylated
3P-RNA (HO-A+AS A24, P-A+AS A24, and 3P-A+AS A24
CIAP; HO-VH1+ AS VH1), or single-stranded 3P-RNA (3P-VH1)
was above the detection limit of this assay but at least higher30 Immunity 31, 25–34, July 17, 2009 ª2009 Elsevier Inc.than 1000 nM (Figures 6D–6G). Consistent with the magnitude
of IFN-a-inducing activity in monocytes, the magnitude of
RIG-I binding of IFN-a inducing (3P-A+AS A24) and of non-
IFN-a-inducing (3P-A+AS23, 3P-A+AS A20, compare Figure 6C
with Figure S3A) 50 triphosphate RNA differed 4- to 5-fold
(Figure 6E). For these studies, we used purified (His6)-tagged
RIG-I protein analyzed by SDS-PAGE and Coomassie Blue
staining (Figure 6H). These results demonstrate that RIG-I
activity of RNA is associated with high-affinity binding but that
binding to RIG-I is not sufficient for RIG-I activation.
DISCUSSION
Well-characterized RNA molecules are crucial for a sound anal-
ysis of RNA functions. Here, we made use of a protocol for
a complete chemical synthesis of 50 triphosphate RNA. By using
these chemically defined RNAmolecules, we identified the exact
molecular structure for RIG-I binding and activation (Figure 7).
Immunity
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required for full activation of RIG-I and that the 50 triphosphate
can not be replaced by 50 monophosphate or 50OHwithout losing
substantial IFN-a-inducing activity; (2) that the recognition of 50
triphosphate requires a short double strand spanning at least
19 nucleotides and encompassing the 50 nucleotide carrying
the triphosphate—single-stranded RNA is not sufficient to
support recognition of 50 triphosphate RNA—; and (3) a blunt
end at the triphosphate end but not at the nontriphosphate end
of the RNA supports recognition by RIG-I, a 30 overhang at the
50 triphosphate end decreases, and any 50 overhang at the 50
triphosphate end abolishes the activity. Structure-dependent
IFN-a-inducing activity of chemically defined RNA molecules
was confirmed in the mouse system and required RIG-I and
IPS-1 but not MDA-5. RIG-I binding and RIG-I ATPase activity
were structure dependent, with the triphosphate being strictly
required for effective RIG-I binding of short RNA molecules
and the ATPase activity being strongly dependent on the pres-
ence of a blunt-end formation at the triphosphate end. Our
data on RIG-I binding andRIG-I ATPase activity are in agreement
with the results obtained by Cui and colleagues (Cui et al., 2008)
but inconsistent with Takahashi and colleagues (Takahasi et al.,
2008); such an outcome may partially be due to the different
nature of the RNA ligand used.
So far, in the literature most studies agree on the fact that
single-stranded 50 triphosphate RNA is sufficient to bind to and
activate RIG-I (Cui et al., 2008; Hornung et al., 2006; Pichlmair
et al., 2006; Plumet et al., 2007; Saito et al., 2008; Takahasi
et al., 2008). Of note, these studies including our own previous
work used in vitro transcription for generation of 50 triphosphate
RNAwithout analyzing the purity and identity of those RNAmole-
cules. However, it has been observed that during in vitro tran-
scription with T7 RNA polymerase, self-coded 30 extension of
run-off transcripts produces aberrant products including size-
variable extensions with complementarity to the correct tran-
Figure 7. Molecular Structure of RIG-I Ligand
Optimal RIG-I ligand activity requires short double-stranded RNA containing at
least one 50 triphosphate. The nucleoside carrying the 50 triphosphate needs to
be part of the Watson-Crick base pairing (GU wobble base pairing less effi-
cient), and pppA, pppG, and pppU are preferred over pppC. Although over-
hangs at the nontriphosphorylated end of the double-stranded RNA have no
major impact on RIG-I activity, a 30 overhang at the 50 triphosphorylated end
impairs RIG-I activity.script (Cazenave and Uhlenbeck, 1994; Triana-Alonso et al.,
1995). In addition to our chemical approach to 50 triphosphate
RNA, we established a protocol for in vitro transcription that
avoids such RNA-template-dependent RNA synthesis, thereby
confirming that unintended formation of double-stranded RNA
in fact is the cause of RIG-I activity of in vitro-transcribed RNA.
Reverse cloning and sequencing of RNA species confirmed
that transcript-coded ‘‘de novo’’ synthesis and self-coding intra-
molecular 30 extension occur and can form RNA duplexes that
are consistent with the structural requirements for RNA RIG-I
ligands (blunt end, short double strand, 50 triphosphate) respon-
sible for the RIG-I-stimulating activity of in vitro-transcribed RNA.
It is interesting to note that the use of undefined RNA molecules
generated by in vitro transcription has led to confusion in the
past. In the seminal work on RNA interference by Fire and Mello
(Fire et al., 1998), the use of gel-purified RNA finally provided the
evidence that only antisense but not sense RNA silences the
sense strand, thereby ending the uncertainty on this in the liter-
ature and paving the way for RNAi. Another intriguing parallel
to RNAi is that it now turns out that short double-stranded
RNA is sufficient for the recognition of 50 triphosphate RNA by
RIG-I and that long double-stranded RNA, initially thought to
be required, is not. In the RNAi field, the possibility to use
synthetic short double-stranded RNA (siRNA) boosted the appli-
cability of this approach. Likewise, the possibility to use short
double-stranded RNA molecules instead of long double-
stranded RNA to provoke the full spectrum of antiviral activities
via RIG-I may facilitate the therapeutic application. In addition,
because the structural requirements are characterized on
a molecular level, functional activities of both RNAi and RIG-I
can be combined in one RNA molecule.
Our results support the view that recognition of viral infection
by RIG-I will always require the presence of double-stranded
RNA, at least of short double-stranded RNA. Not only is
double-stranded RNA present in double-strand RNA viruses
but substantial amounts of cytosolic double-stranded RNA are
also produced during the replicative life cycle of positive
single-strand RNA viruses (Weber et al., 2006). In agreement
with the requirement of double-stranded RNA for RIG-I recogni-
tion, double-strand and positive single-strand RNA viruses are
indeed recognized by RIG-I (Kato et al., 2006; Loo et al., 2008).
However, at first sight, this seemed less clear for RIG-I-mediated
detection of negative single-strand RNA viruses (Kato et al.,
2006; Loo et al., 2008) for which no double-stranded RNA can
be detected (Pichlmair et al., 2006; Weber et al., 2006), but still
viral genomic single-stranded RNA activates RIG-I (Hornung
et al., 2006; Pichlmair et al., 2006). However, the antibody
used to demonstrate the absence of double-stranded RNA
(Pichlmair et al., 2006; Weber et al., 2006) is limited to the detec-
tion of double-stranded RNA longer than 40 bases (Bonin et al.,
2000). Our analysis of sequence data revealed that genomes of
negative-strand viruses known to activate RIG-I contain 50 and 30
sequences that form a short double strand with a perfect blunt
end (panhandle) and with a 50 adenosine carrying the triphos-
phate group. For influenza virus, such panhandle structures
(Hofacker et al., 2004) were shown to serve as a RNA transcrip-
tion initiation site for the viral RNA polymerase complex (Portela
and Digard, 2002). Of note, mismatches and bulge loops as
those present in the panhandle of negative-strand RNA virusesImmunity 31, 25–34, July 17, 2009 ª2009 Elsevier Inc. 31
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more, triphosphate-A (pppA) is the most abundant first nucleo-
tide in genomes of RNA viruses (exceptions are Ebola, pppU;
and Hepatitis C, pppG).
Genomic single-stranded RNA of negative-strand RNA viruses
is thought to be encapsidated by structural proteins. However,
recent data (Strahle et al., 2007) suggest that activation of
RIG-I by Sendai virus is due to contamination with defective viral
genomes (DI-H4) that occur during infection and do not show
encapsidation and therefore can form panhandle structures
in vivo. It is well accepted that negative-strand RNA viruses for
replication require a highly conserved promoter at both ends of
the genome. For Vesicular Stomatitis Virus (VSV) it was shown
that during replication, artificially introduced extra nucleotides
at the 50 end of the VSV (-) ssRNA genome are eliminated,
whereas extra nucleotides at the 30 end are not tolerated at all
(Pattnaik et al., 1992). Thus, blunt-end 50 triphosphate short
double-strand RNA formation, the consequence of the require-
ment of two conserved promoters, represents a negative-strand
virus-associated molecular pattern detected by RIG-I.
Short (23-mer and longer) blunt-end double-stranded RNA
without triphosphate was proposed to be the key feature for
RIG-I activation (Marques et al., 2006). Although our data are in
agreement with the importance of a blunt end for RIG-I activa-
tion, we show that full RIG-I activation requires the additional
presence of a 50 triphosphate; furthermore, a blunt end at the
nontriphosphate end is not required. Our data are also partially
in agreement with the notion by Takahasi and colleagues that
a longer 30 overhang decreases the activity of a 25-mer
double-stranded RNA oligonucleotide (Takahasi et al., 2008).
On the other hand, Takahasi and colleagues (Takahasi et al.,
2008) suggested that blunt-end 50 monophosphate double-
stranded RNA is sufficient for full RIG-I activation, a conclusion
that is not supported by our findings. However, 50 monophos-
phate may be sufficient to support partial activation of RIG-I,
but on a lower level.
Kato and colleagues (Kato et al., 2008) reported the activation
of RIG-I by ‘‘short’’ double-stranded RNAwithout the need of a 50
triphosphate or blunt-end conformation in order to activateRIG-I.
In our study, the term short double-stranded RNA refers to RNA
molecules of 20 bp that is much shorter than the lengths of
‘‘short‘‘ double-stranded RNA reported earlier (300 and 2000 bp)
(Kato et al., 2008). This may explain why no 50 triphosphate
dependency was seen by this group. Another group confirmed
the 50 triphosphate requirement, yet suggested that single-
stranded homopolyuridine or homopolyriboadenine motifs,
because they are present in genomes of RNA viruses, constitute
a key structural element of RIG-I recognition (Saito et al., 2008).
Although the 30 sequence under certain circumstances may
contribute to RIG-I activity, our results provide no indication
that homopolyuridine or homopolyriboadenine motifs are in fact
required for full binding and activation of RIG-I by 50 triphosphate
RNA. Of note, because in vitro transcription was used in this
study, self-coded 30 extension of RNA transcripts (fold back)
and transcript coded de novo synthesismight have been respon-
sible for the production of aberrant dsRNA and thus RIG-I activa-
tion (Cazenave and Uhlenbeck, 1994; Triana-Alonso et al., 1995).
Interestingly, data from Gondai and colleagues support the
requirement of a double-stranded 50 triphosphate structure32 Immunity 31, 25–34, July 17, 2009 ª2009 Elsevier Inc.even for in vitro-transcribed RNA with regards to RIG-I activation
(Gondai et al., 2008). In their study, the introduction of increasing
numbers of guanosines at the 50 end of in vitro-transcribed
shRNA reduced the IFN induction by shRNA. By introducing
guanosines at the 50 end, overhangs of the 50 triphosphate end
are generated, thereby leading to the disruption of the double-
strand conformation resulting in a loss of RIG-I activity.
The identification of the exact molecular structure required for
RIG-I activation now allows generation of defined synthetic 50
triphosphate RNA ligands for RIG-I with reproducible and
predictable induction of potent antiviral responses. Synthetic 50
triphosphate RNA has a number of advantages over 50 triphos-
phate RNA generated by in vitro transcription: First, purity and
identity of synthetic 50 triphosphate RNA is independent of the
respective sequence. Second, unlike with in vitro transcription,
the synthetic approach allows modification of the base compo-
sition at the 50 triphosphate end of the RNA as exemplified by
defining adenosine or guanosine as the preferred 50 nucleosides.
Third, large-scale synthesis based on a process that includes
standard RNA chemistry with all possibilities of additional modi-
fications can be used. Fourth, the biological activity of synthetic
50 triphosphate RNA is superior to in vitro-transcribed RNA.
These advantages of the synthetic 50 triphosphate RNA will
greatly improve the development of such RNA oligonucleotides
for the treatment of viral infection and cancer.
EXPERIMENTAL PROCEDURES
Chemical Synthesis of Triphosphate Oligoribonucleotides
Oligoribonucleotides containing a free 50 OH terminus were synthesized on an
ABI 392 synthesizer with commercial 50 Silyl 20ACE-protected amidites from
Dharmacon. Solid phase triphosphorylation of oligoribonucleotides was per-
formed with an improved version of the protocol developed by Ludwig and
Eckstein (Ludwig and Eckstein, 1989) (unpublished data). After internucleotide
phosphate and base deprotection, 50 triphosphorylated 20-ACE-protected
derivates were purified by RP-HPLC and then the 20-OH protecting groups
were removed under standard deprotection conditions at pH = 3.8, 60C.
MALDI-ToF analysis was performed by Metabion (Martinsried, Germany).
Monophosphate RNA, Nonmodified RNA,
and In Vitro-Transcribed RNA
Monophosphate RNA and nonmodified RNA oligoribonucleotides (ORNs)
were synthesized by commercial providers (Metabion and Biomers). The
sequences are listed in Table S1. ivt3P-G and ivt3P-Gaca were generated
by in vitro transcription (IVT) with a commercial in vitro T7 transcription kit
(Epicenter). For generation of DNA-template-dependent in vitro-transcribed
RNA, the T7-promoter region 50-CAGTAATAGGACTCACTATAG-30 was
hybridized with the promoter+template strand (ivt3P-G: 50- AAA GTG TGT
GTG TGT GTG TGT GTC TAT AGT GAG TCG TAT TAC TG -30; ivt3P-Gaca:
50-TGT GTG TGT GTG TGT GTG TGT GTC TAT AGT GAG TCG TAT TAC
TG-30 ; IVT2: 50- GTC GTC GTC GTC GTC GTC GTC GTC GTC GTC TAT
AGT GAG TCG TAT TAC TG -30) and directly used as a template for the
in vitro transcription reaction. For generation of ivt3P-G without uridine
(ivt3P–G w/o U) and ivt3P-Gaca without uridine (ivt3P-Gaca w/o U), the
in vitro transcription was performed in the absence of UTP. Single bands
from ivt3P-Gaca and in vitro transcripts corresponding to predicted panhandle
structures of Rabies virus genomes were PAGE purified: in brief, the 3P-RNA
with estimated size was eluted from a 50% urea PAGE-gel slice by incubation
in 0.3 M sodiumacetate (pH 5.4) and subsequent precipitation in 70% ethanol.
RNaseT (Fermentas) digestion under native conditions was performed accord-
ing to the manufacturer’s protocol. RNaseT digest under denaturating condi-
tions occurred 30 min at 50C in 6 M urea, 17.8 mM Na-citrate at pH 3.5,
0.9 mM EDTA (Nallagatla et al., 2007).
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RNA was cloned by a protocol that was similar to a method introduced by Lee
and colleagues (Lee and Ambros, 2001) for small-RNA cloning: PAGE-purified
RNA was polyadenylated with poly(A) polymerase (Epicenter). The cDNA was
cloned into the vector pLib (Clontech) with the Creator SMART cDNA Library
Construction Kit (Clontech) according to the manufacturer’s protocol. Plasmid
DNA was prepared from single E. coli colonies and sequenced with M13
forward primer. For the alternative approach, RNA molecules were dephos-
phorylated with calf intestine phosphatase (CIP), phosphorylated with T4 poly-
nucleotide kinase (PNK), purified and converted into cDNA-libraries as
described (Hafner et al., 2008) with bar-coded 30 adapters (Vigneault et al.,
2008), and submitted for a one-well 454 sequencing reaction.
Cell Culture
Human PBMCs were isolated from whole human blood of healthy, voluntary
donors by Ficoll-Hypaque density gradient centrifugation (Biochrom Berlin).
Plasmacytoid dendritic cells (PDCs) were positively depleted with magneti-
cally labeled anti-CD304 antibody (Miltenyi Biotec). Untouched monocytes
were obtained by negative depletion from PBMCs according to the manufac-
turer’s instructions (Human Monocyte Isolation Kit II, Miltenyi Biotec). Viability
of all cells was above 95%, as determined by trypan blue exclusion. If not indi-
cated otherwise, 400,000 cells (PBMCs) or 200,000 cells (monocytes) were
cultured in 96-well plates for stimulation experiments. Cells were kept in
RPMI 1640 containing 10% FCS, 1.5 mM L-glutamine, 100 U/ml penicillin,
and 100 mg/ml streptomycin. All compounds were tested for endotoxin
contamination prior to use. Mouse embryonic fibroblasts (MEFs) from MDA-
5/, RIG-I/, and IPS-1/ mice were prepared as described (Kato et al.,
2006). For transfection, 0.2 ug nucleic acid and 0.5 ul Lipofectamine (Invitro-
gen) were mixed in 50 ul Optimem (Invitrogen), incubated for 20 min, and
added to the well containing 200,000 cells. The studies were approved by
the local ethic committee (Ethikkommission der Medizinischen Fakulta¨t Bonn).
Detection of Cytokines
The amount of IFN-a production was determined with the IFN-a module set
from Bender MedSystems. The ELISA assay was performed according to
the manufacturer’s protocol. The concentration of cytokines was determined
by the standard curve obtained using known amounts of recombinant cyto-
kines.
Flow Cytometry
Cell purity was assessed by FACS analysis of cell-surface antigens with
a FACS LSRII (BD Biosciences). Human monocytes were stained with anti-
body against CD14-FITC or CD14-APC, and cell purity was between 83%
and 99%. Human PDCs were positively labeled with antibody against
CD123-PE and HLA-DR-PerCp and negatively labeled with antibody against
CD11c-APC and a cocktail to lineage markers (FITC). Antibodies were
purchased from BD PharMingen. Data analysis was performed on viable cells
with CellQuest (BD Biosciences) and Flowjo (Treestar).
Protein Purification and Analysis
(His6)-Flag-tagged RIG-I (HF-RIG-I) was transiently overexpressed in 293T
cells and lysed in a CHAPS containing lysis buffer (150 mM NaCl, 50 mM
Tris/HCl [pH 7.4], 2 mMMgCl2, 1mMDTT, and 1%CHAPS) including protease
inhibitor cocktail (Roche). The lysate was incubated over night at 4Cwith anti-
FLAG beads (Sigma). Anti-FLAG beads were washed subsequently with lysis
buffer and high-salt wash buffer (300mMNaCl, 50mM Tris/HCl [pH 7.4], 5 mM
MgCl2, 1mMDTT, and 0.1%CHAPS). RIG-I-FLAGwas eluted by an addtion of
FLAG-peptide (300 ug/ml) solution to the beads. Purity of recombinant RIG-I
was determined by SDS-PAGE separation and subsequent Coomassie blue
staining (Figure 6H).
ATPase Assay
The ATPase assay was performed in assay buffer (50 mM KCl, 55 mM HEPES
[pH 7.0], 3mMMgCl2, 0.5mMDTT, and 0.1mMATP). For EC50 calculation, the
RNA was titrated in a range from 6 fM to 4 mM. After 30 min of incubation at
37C, the occurrence of ADP was measured with a very sensitive FRET-based
competitive immunoassay (HTRF Transcreener ADP, Cisbio) according to the
manufacturer’s protocol. FRET was measured with an EnVision MultilabelReader (PerkinElmer). In this assay, inhibition of FRET correlates with the
concentration of ADP generated by ATPase activity of RIG-I. ADP concentra-
tions were calculated from an ADP/ATP titration curve according to the manu-
facturer’s protocol.
Alpha Screen RIG-I-Binding Assay
The binding affinity of RNA for (His6)FLAG-tagged RIG-I (HF-RIG-I) was deter-
mined as described (Haas et al., 2008; Latz et al., 2007) by an amplified lumi-
nescent proximity homogenous assay (AlphaScreen; PerkinElmer). In this
assay, purified HF-RIG-I was incubated with increasing concentrations of bio-
tinylated RNA for 1 hr at 37C in buffer (50 mM Tris [pH 7.4], 100 mM NaCl,
0.01% Tween20, and 0.1% BSA) and subsequently incubated for 30 min at
25C with HF-RIG-I-binding Nickel Chelate Acceptor Beads (PerkinElmer)
and biotin-RNA-binding Streptavidine donor beads (PerkinElmer). The donor
bead contains the photosensitizer phtalocyanine, which converts ambient
oxygen into a ‘‘singlet’’ oxygen after illumination with a 680 nm laser light.
During the 4 ms lifetime, the ‘‘singlet’’ oxygen can diffuse up to 200 nm and
activate a thioxene derivative on the acceptor bead that is brought into prox-
imity by interaction of the test molecules bound to the beads. The resulting
chemiluminescence with subsequent activation of a fluorochrome (contained
within the same bead) emitting in the range of 520–620 nm correlates with the
number and proximity of associated beads that is inversely correlated with
the dissociation constant of donor (biotin-RNA) and acceptor (HF-RIG-I).
The assay was performed in wells of 384-well plates (Proxiplate; PerkinElmer).
Plates were analyzed for emitted fluorescence with a multilabel reader (Envi-
sion; PerkinElmer).
SUPPLEMENTAL DATA
Supplemental Data include one table and four figures and can be found
with this article online at http://www.cell.com/immunity/supplemental/
S1074-7613(09)00271-4.
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